수면 보조제 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 수면장애별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Sleep Aids Market size was valued at USD 83.19 Billion in 2024 and is poised to grow from USD 88.14 Billion in 2025 to USD 139.96 Billion by 2033, growing at a CAGR of 5.95% during the forecast period (2026-2033).

Sleep disorders significantly impact individuals' quality of life, contributing to daytime fatigue and a myriad of complications, including challenges in academic and professional settings, mental health issues, and chronic conditions like heart disease and diabetes. Common disorders such as insomnia, sleep apnea, restless legs syndrome, and narcolepsy highlight the pressing need for effective interventions. Treatment options range from traditional medications like pitolisant and modafinil to alternatives including gabapentin, zolpidem, and various supplements. Lifestyle modifications, such as regular exercise and optimal environmental conditions, can enhance sleep quality. However, concerns over side effects associated with sleep aids and the prevalence of medication expiration among patients are likely to hinder growth in the sleep aids market, underscoring the need for safe and effective solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sleep Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sleep Aids Market Segments Analysis

Global Sleep Aids Market is segmented by product type, sleep disorder, distribution channel, end-user and region. Based on product type, the market is segmented into mattresses & pillows, medications, sleep apnea devices, sleep laboratories and other products. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking and other sleep disorders. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, sleep clinics and others. Based on end-user, the market is segmented into adults, children and elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sleep Aids Market

The evolving sleep patterns among people worldwide, influenced by contemporary lifestyles, significantly fuel the expansion of the sleep aids market. Additionally, rising consumer affluence and enhanced access to healthcare services contribute to this growth, as more individuals seek effective solutions for sleep-related issues. The heightened awareness of the importance of quality sleep for overall well-being propels the demand for sleep aids, leading to a broader acceptance and utilization of various products designed to improve sleep quality. As a result, this combination of changing habits and increased accessibility to health resources positions the sleep aids market for continuous growth and innovation.

Restraints in the Sleep Aids Market

The Sleep Aids market faces challenges due to the rising complexity of innovative technologies that complicate the treatment of sleep disorders. Additionally, the absence of standardized guidelines and documentation for the use of sleep medications hinders effective application. Issues related to improper settings and configurations of sleep devices further exacerbate these difficulties, contributing to a stagnation in market growth. These factors collectively impede the potential advancement of the market, as they create barriers to the effective management and treatment of sleep-related conditions, highlighting the need for improved regulations and better technological integration in this sector.

Market Trends of the Sleep Aids Market

The global sleep aids market is witnessing a notable surge in demand, driven by a rising prevalence of sleep disorders such as insomnia, restless leg syndrome, and narcolepsy. Consumers are increasingly turning to innovative sleep-improving products, including specialized pillows and mattresses designed to enhance comfort and promote restful sleep. This trend is further fueled by heightened awareness of the importance of sleep for overall health, leading to a growing inclination towards natural and pharmacological sleep solutions. As lifestyles become more fast-paced and stress levels rise, the market for sleep aids is projected to expand significantly, reflecting a heightened focus on achieving quality sleep for improved well-being.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Customer & Buying Criteria Analysis

Global Sleep Aids Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Mattresses & Pillows
• Medications
  • Prescription-Based
  • Over-The-Counter (OTC)
• Sleep Apnea Devices
  • Positive Airway Pressure (PAP) Devices
  • Adaptive Servo-Ventilation (ASV) Devices
  • Oral Appliances
  • Masks & Accessories
• Sleep Laboratories
• Other Products
  • Sleep Tracking Devices
  • White Noise Machines

Global Sleep Aids Market Size by Sleep Disorder & CAGR (2026-2033)

• Market Overview
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Sleep Walking
• Other Sleep Disorders

Global Sleep Aids Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Sleep Clinics
• Others

Global Sleep Aids Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Adults
• Children
• Elderly

Global Sleep Aids Market Size & CAGR (2026-2033)

• North America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • USA
  • Canada
• Europe (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SleepMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vanda Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations